Albert David Ltd

Ticker: ALBERTDAVD
Decent 48/100

☆ Add to Watchlist

Investing Reference

Price
801.05
Market Cap
457.17
Debt/Equity
0.0314
ROE %
4.439
PB
1.1648
Promoter %
62.237
Pledge %
0.000
1Y Rev Growth %
-10.633
5Y Rev Growth %
2.739
NP Margin %
4.585
NP Margin 5Y Avg %
10.350

Trading Reference

1M Return %
-2.971
6M Return %
-5.049
1Y Return %
-42.424
% Away 52W High
92.248
% Away 52W Low
5.042
Daily Volume
1726
Investment Verdict
Hold
Score 72/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 17/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Albert David Ltd is currently trading near a key support level, with recent volume indicating strong buying interest. If the stock can break above the resistance level at ₹X, there is potential for a price increase. However, if it falls below the support level at ₹Y, it may face significant downside risk.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Albert David Ltd is a prominent player in the Indian pharmaceutical and healthcare sector, specializing in the manufacture and distribution of high-quality healthcare products. Catering to a diverse audience, including hospitals and retail pharmacies, the company is committed to improving health outcomes across the nation. With a strong focus on innovation and quality, Albert David Ltd stands out for its extensive product range and reliable service, making it a trusted partner in healthcare.

  • Established leader in the pharmaceutical industry
  • Wide range of healthcare products
  • Focus on quality and innovation
  • Trusted by hospitals and pharmacies
  • Commitment to improving health outcomes
  • Strong market presence in India

Investment Thesis

Albert David Ltd stands out due to its strong promoter group and credibility in the market. With a robust focus on digital services, the company is well-positioned for growth. Additionally, its attractive valuation compared to peers makes it a compelling investment opportunity for retail investors.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Significant growth potential in digital services aligns with market trends.
  • Attractive valuation metrics compared to industry peers provide a margin of safety.
  • Established brand presence in the healthcare sector supports revenue stability.
  • Strategic initiatives in innovation and expansion are set to drive future growth.

Opportunity vs Risk

Opportunities
  • Growing demand for healthcare products
  • Expansion into new markets
  • Strong brand recognition
  • Rising e-commerce sales
  • Strategic partnerships with suppliers
Risks ⚠️
  • Regulatory changes affecting operations
  • Intense competition in the sector
  • Supply chain disruptions
  • Fluctuating raw material costs
  • Economic downturns impacting sales

Peer Perspective

Albert David Ltd trades at a discount to peers like Cipla and Sun Pharma, with a P/E ratio reflecting its growth potential. A rerating could occur if the company achieves consistent margin stability and accelerates revenue growth.

Future Outlook

Albert David Ltd is well-positioned for growth in the coming quarters, provided it maintains strong execution and cost control measures. Continued focus on innovation and market expansion will be key to unlocking its full potential.

AI FAQs for Retail Users

  • Q: What does Albert David Ltd do?
    A: Albert David Ltd is involved in manufacturing and marketing pharmaceutical products and healthcare solutions.
  • Q: Is Albert David Ltd a good investment?
    A: Investment decisions should be based on individual research and financial goals. Consult a financial advisor.
  • Q: What are the recent financial results of Albert David Ltd?
    A: You can find the latest financial results in their quarterly reports available on their website.
  • Q: How can I buy shares of Albert David Ltd?
    A: Shares can be purchased through a registered stockbroker or an online trading platform.
  • Q: What are the risks of investing in Albert David Ltd?
    A: Like all investments, risks include market volatility, regulatory changes, and company-specific factors.
📊 Stock Investment Checklist (100 Points)
Albert David Ltd • Updated: 2025-09-17 01:09:43
  • 8
    Business
    High
    The company operates in the pharmaceutical sector, which is generally future-ready with a clear business model.
  • 10
    Growth
    High
    Revenue and profit growth have been inconsistent over the past few years.
  • 10
    Profitability
    High
    ROE and ROCE are moderate, but cash flow from operations is not consistently strong.
  • 6
    Valuation
    Good
    P/E and P/B ratios are higher than industry peers, indicating potential overvaluation.
  • 7
    Balance
    High
    The company has a manageable debt/equity ratio, but liquidity could be improved.
  • 8
    Governance
    High
    Promoter holding is decent, but there are some concerns regarding disclosures.
  • 5
    Drivers
    Good
    Growth catalysts are limited, and execution risks are present.
  • 2
    Technicals
    Low
    Market sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100 • Decent
While Albert David Ltd operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 65/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.